These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27109517)

  • 1. Bioactivity Focus of α-Cyano-4-hydroxycinnamic acid (CHCA) Leads to Effective Multifunctional Aldose Reductase Inhibitors.
    Zhang L; Li YF; Yuan S; Zhang S; Zheng H; Liu J; Sun P; Gu Y; Kurihara H; He RR; Chen H
    Sci Rep; 2016 Apr; 6():24942. PubMed ID: 27109517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antioxidation capacity endowed to a mixed type aldose reductase inhibitor leads to a promising anti-diabetic complications agent.
    Liu Y; Mo H; Zhang K; Yin M; Yuan S; Li Y; Li Y; Zhu W; Fan Y; Zeng Y; Kurihara H; He R; Chen H
    Bioorg Chem; 2022 Mar; 120():105624. PubMed ID: 35065464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation on SIRT1-PGC-1α/Nrf2 pathway together with selective inhibition of aldose reductase makes compound hr5F a potential agent for the treatment of diabetic complications.
    Wang Z; Yuan S; Li Y; Zhang Z; Xiao W; Tang D; Ye K; Liu Z; Wang C; Zheng Y; Nie H; Chen H
    Biochem Pharmacol; 2018 Apr; 150():54-63. PubMed ID: 29371030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
    Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications.
    Kumar M; Choudhary S; Singh PK; Silakari O
    Future Med Chem; 2020 Jul; 12(14):1327-1358. PubMed ID: 32602375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (5-Hydroxy-4-oxo-2-styryl-4
    Chen H; Zhang X; Zhang X; Liu W; Lei Y; Zhu C; Ma B
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33158254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Search for non-acidic ALR2 inhibitors: Evaluation of flavones as targeted agents for the management of diabetic complications.
    Vyas B; Choudhary S; Singh PK; Kumar M; Verma H; Singh M; Malik AK; Silakari O
    Bioorg Chem; 2020 Mar; 96():103570. PubMed ID: 31978681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K1 prevents diabetic cataract by inhibiting lens aldose reductase 2 (ALR2) activity.
    Thiagarajan R; Varsha MKNS; Srinivasan V; Ravichandran R; Saraboji K
    Sci Rep; 2019 Oct; 9(1):14684. PubMed ID: 31604989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
    Carbone V; Zhao HT; Chung R; Endo S; Hara A; El-Kabbani O
    Bioorg Med Chem; 2009 Feb; 17(3):1244-50. PubMed ID: 19121944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ponalrestat: a potent and specific inhibitor of aldose reductase.
    Ward WH; Sennitt CM; Ross H; Dingle A; Timms D; Mirrlees DJ; Tuffin DP
    Biochem Pharmacol; 1990 Jan; 39(2):337-46. PubMed ID: 2105733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.
    Ji Y; Chen X; Chen H; Zhang X; Fan Z; Xie L; Ma B; Zhu C
    Bioorg Med Chem; 2019 Apr; 27(8):1658-1669. PubMed ID: 30858026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
    Chen H; Zhang X; Zhang X; Fan Z; Liu W; Lei Y; Zhu C; Ma B
    Bioorg Med Chem; 2020 Oct; 28(20):115699. PubMed ID: 33069078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Length and rigidity of the spacer impact on aldose reductase inhibition of the 5F-like ARIs in a dual-occupied mode.
    Zeng Y; Zheng Z; Yin M; Li J; Xu J; Tang Y; Zhang K; Liu Z; Chen S; Sun P; Chen H
    Bioorg Chem; 2023 Feb; 131():106300. PubMed ID: 36455484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
    Imran A; Tariq Shehzad M; Al Adhami T; Miraz Rahman K; Hussain D; Alharthy RD; Shafiq Z; Iqbal J
    Bioorg Chem; 2021 Oct; 115():105164. PubMed ID: 34314916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition.
    Shehzad MT; Hameed A; Al-Rashida M; Imran A; Uroos M; Asari A; Mohamad H; Islam M; Iftikhar S; Shafiq Z; Iqbal J
    Bioorg Chem; 2019 Nov; 92():103244. PubMed ID: 31541804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity.
    Zhu S; Zhang S; Hao X; Qin X; Parveen S; Yang S; Ma B; Zhu C
    J Enzyme Inhib Med Chem; 2016; 31(sup1):126-130. PubMed ID: 27153454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Hydroxypyrazole as a bioisostere of the acetic acid moiety in a series of aldose reductase inhibitors.
    Papastavrou N; Chatzopoulou M; Pegklidou K; Nicolaou I
    Bioorg Med Chem; 2013 Sep; 21(17):4951-7. PubMed ID: 23891165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.
    Kovacikova L; Prnova MS; Majekova M; Bohac A; Karasu C; Stefek M
    Molecules; 2021 May; 26(10):. PubMed ID: 34066081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(Aroyl)-N-(arylmethyloxy)-α-alanines: Selective inhibitors of aldose reductase.
    Nencetti S; La Motta C; Rossello A; Sartini S; Nuti E; Ciccone L; Orlandini E
    Bioorg Med Chem; 2017 Jun; 25(12):3068-3076. PubMed ID: 28392277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of C7 modifications on benzothiadiazine-1,1-dioxide derivatives on their inhibitory activity and selectivity toward aldose reductase.
    Zhang S; Chen X; Parveen S; Hussain S; Yang Y; Jing C; Zhu C
    ChemMedChem; 2013 Apr; 8(4):603-13. PubMed ID: 23136050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.